Literature DB >> 27512072

Interrelationship of Primary Virus Replication, Level of Latency, and Time to Reactivation in the Trigeminal Ganglia of Latently Infected Mice.

Harry H Matundan1, Kevin R Mott1, Sariah J Allen1, Shaohui Wang1, Catherine J Bresee2, Yasamin N Ghiasi3, Terrence Town3, Steven L Wechsler4, Homayon Ghiasi5.   

Abstract

UNLABELLED: We sought to determine the possibility of an interrelationship between primary virus replication in the eye, the level of viral DNA in the trigeminal ganglia (TG) during latency, and the amount of virus reactivation following ocular herpes simplex virus type 1 (HSV-1) infection. Mice were infected with virulent (McKrae) or avirulent (KOS and RE) strains of HSV-1, and virus titers in the eyes and TG during primary infection, level of viral gB DNA in TG on day 28 postinfection (p.i.), and virus reactivation on day 28 p.i. as measured by explant reactivation were calculated. Our results suggest that the avirulent strains of HSV-1, even after corneal scarification, had lower virus titers in the eye, had less latency in the TG, and took a longer time to reactivate than virulent strains of HSV-1. The time to explant reactivation of avirulent strains of HSV-1 was similar to that of the virulent LAT((-)) McKrae-derived mutant. The viral dose with the McKrae strain of HSV-1 affected the level of viral DNA and time to explant reactivation. Overall, our results suggest that there is no absolute correlation between primary virus titer in the eye and TG and the level of viral DNA in latent TG and time to reactivation. IMPORTANCE: Very little is known regarding the interrelationship between primary virus replication in the eye, the level of latency in TG, and the time to reactivate in the mouse model. This study was designed to answer these questions. Our results point to the absence of any correlation between the level of primary virus replication and the level of viral DNA during latency, and neither was an indicator of how rapidly the virus reactivated following explant TG-induced reactivation.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27512072      PMCID: PMC5044812          DOI: 10.1128/JVI.01373-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

Review 1.  Human herpes viruses latent infection in the nervous system.

Authors:  I Steiner
Journal:  Immunol Rev       Date:  1996-08       Impact factor: 12.988

2.  Strain specificity of spontaneous and adrenergically induced HSV-1 ocular reactivation in latently infected rabbits.

Authors:  J M Hill; M A Rayfield; Y Haruta
Journal:  Curr Eye Res       Date:  1987-01       Impact factor: 2.424

3.  Spontaneous ocular shedding of HSV-1 in latently infected rabbits.

Authors:  E J Berman; J M Hill
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-04       Impact factor: 4.799

4.  Herpes simplex virus latent phase transcription facilitates in vivo reactivation.

Authors:  J M Hill; F Sedarati; R T Javier; E K Wagner; J G Stevens
Journal:  Virology       Date:  1990-01       Impact factor: 3.616

5.  Fewer latent herpes simplex virus type 1 and cytotoxic T cells occur in the ophthalmic division than in the maxillary and mandibular divisions of the human trigeminal ganglion and nerve.

Authors:  Katharina Hüfner; Anja Horn; Tobias Derfuss; Christine Glon; Inga Sinicina; Viktor Arbusow; Michael Strupp; Thomas Brandt; Diethilde Theil
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

6.  Reactivation phenotype in rabbits of a herpes simplex virus type 1 mutant containing an unrelated antiapoptosis gene in place of latency-associated transcript.

Authors:  Ling Jin; Guey-Chuen Perng; Dale Carpenter; Kevin R Mott; Nelson Osorio; Julia Naito; David J Brick; Clinton Jones; Steven L Wechsler
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

7.  Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis.

Authors:  B A Barron; L Gee; W W Hauck; N Kurinij; C R Dawson; D B Jones; K R Wilhelmus; H E Kaufman; J Sugar; R A Hyndiuk
Journal:  Ophthalmology       Date:  1994-12       Impact factor: 12.079

8.  Overexpression of interleukin-2 by a recombinant herpes simplex virus type 1 attenuates pathogenicity and enhances antiviral immunity.

Authors:  Homayon Ghiasi; Yanira Osorio; Guey-Chuen Perng; Anthony B Nesburn; Steven L Wechsler
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Characterization of baculovirus-expressed herpes simplex virus type 1 glycoprotein K.

Authors:  H Ghiasi; S Slanina; A B Nesburn; S L Wechsler
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

10.  Role of dendritic cells in enhancement of herpes simplex virus type 1 latency and reactivation in vaccinated mice.

Authors:  Kevin R Mott; Homayon Ghiasi
Journal:  Clin Vaccine Immunol       Date:  2008-10-29
View more
  15 in total

1.  The Absence of Lymphotoxin-α, a Herpesvirus Entry Mediator (HVEM) Ligand, Affects Herpes Simplex Virus 1 Infection In Vivo Differently than the Absence of Other HVEM Cellular Ligands.

Authors:  Shaohui Wang; Satoshi Hirose; Homayon Ghiasi
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

2.  Roles of M1 and M2 Macrophages in Herpes Simplex Virus 1 Infectivity.

Authors:  Dhong Hyun Lee; Homayon Ghiasi
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

3.  An M2 Rather than a TH2 Response Contributes to Better Protection against Latency Reactivation following Ocular Infection of Naive Mice with a Recombinant Herpes Simplex Virus 1 Expressing Murine Interleukin-4.

Authors:  Dhong Hyun Lee; Homayon Ghiasi
Journal:  J Virol       Date:  2018-04-27       Impact factor: 5.103

4.  Absence of Signal Peptide Peptidase, an Essential Herpes Simplex Virus 1 Glycoprotein K Binding Partner, Reduces Virus Infectivity In Vivo.

Authors:  Shaohui Wang; Homayon Ghiasi
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

5.  Knockout of signal peptide peptidase in the eye reduces HSV-1 replication and eye disease in ocularly infected mice.

Authors:  Shaohui Wang; Ujjaldeep Jaggi; Homayon Ghiasi
Journal:  PLoS Pathog       Date:  2022-10-10       Impact factor: 7.464

Review 6.  Corneal pain and experimental model development.

Authors:  Tina B McKay; Yashar Seyed-Razavi; Chiara E Ghezzi; Gabriela Dieckmann; Thomas J F Nieland; Dana M Cairns; Rachel E Pollard; Pedram Hamrah; David L Kaplan
Journal:  Prog Retin Eye Res       Date:  2018-11-16       Impact factor: 21.198

7.  Expression of Murine CD80 by Herpes Simplex Virus 1 in Place of Latency-Associated Transcript (LAT) Can Compensate for Latency Reactivation and Anti-apoptotic Functions of LAT.

Authors:  Ujjaldeep Jaggi; Harry H Matundan; Kati Tormanen; Shaohui Wang; Jack Yu; Kevin R Mott; Homayon Ghiasi
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

8.  The Latency-Associated Transcript Inhibits Apoptosis via Downregulation of Components of the Type I Interferon Pathway during Latent Herpes Simplex Virus 1 Ocular Infection.

Authors:  Kati Tormanen; Sariah Allen; Kevin R Mott; Homayon Ghiasi
Journal:  J Virol       Date:  2019-05-01       Impact factor: 6.549

9.  CD80 Plays a Critical Role in Increased Inflammatory Responses in Herpes Simplex Virus 1-Infected Mouse Corneas.

Authors:  Kati Tormanen; Shaohui Wang; Homayon Ghiasi
Journal:  J Virol       Date:  2020-01-06       Impact factor: 6.549

10.  Restoring Herpesvirus Entry Mediator (HVEM) Immune Function in HVEM-/- Mice Rescues Herpes Simplex Virus 1 Latency and Reactivation Independently of Binding to Glycoprotein D.

Authors:  Kati Tormanen; Shaohui Wang; Ujjaldeep Jaggi; Homayon Ghiasi
Journal:  J Virol       Date:  2020-07-30       Impact factor: 6.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.